Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
2,998
-18
-0.6% -$6.16K 0.11% 124
2026
Q1
$1.06M Sell
3,016
-588
-16% -$210K 0.12% 117
2025
Q4
$1.18M Sell
3,604
-78
-2% -$24.7K 0.13% 102
2025
Q3
$1.04M Buy
3,682
+1,492
+68% +$433K 0.12% 106
2025
Q2
$611K Sell
2,190
-90
-4% -$25.5K 0.08% 144
2025
Q1
$710K Buy
2,280
+144
+7% +$42.5K 0.09% 131
2024
Q4
$557K Sell
2,136
-44
-2% -$13.1K 0.07% 147
2024
Q3
$702K Buy
2,180
+5
+0.2% +$1.64K 0.09% 129
2024
Q2
$680K Buy
2,175
+77
+4% +$22.6K 0.09% 127
2024
Q1
$597K Buy
2,098
+18
+0.9% +$5.27K 0.08% 138
2023
Q4
$599K Buy
2,080
+3
+0.1% +$817 0.08% 131
2023
Q3
$558K Buy
2,077
+55
+3% +$13.7K 0.09% 135
2023
Q2
$449K Buy
2,022
+225
+13% +$52.2K 0.07% 162
2023
Q1
$434K Sell
1,797
-163
-8% -$40K 0.07% 149
2022
Q4
$451K Sell
1,960
-544
-22% -$146K 0.08% 146
2022
Q3
$564K Sell
2,504
-15
-0.6% -$3.64K 0.11% 113
2022
Q2
$613K Buy
2,519
+19
+0.8% +$4.66K 0.11% 110
2022
Q1
$605K Buy
2,500
+5
+0.2% +$1.15K 0.1% 117
2021
Q4
$561K Sell
2,495
-175
-7% -$36.9K 0.09% 120
2021
Q3
$568K Buy
2,670
+313
+13% +$72K 0.1% 104
2021
Q2
$575K Buy
2,357
+804
+52% +$198K 0.1% 101
2021
Q1
$386K Buy
1,553
+5
+0.3% +$1.19K 0.07% 117
2020
Q4
$356K Buy
1,548
+4
+0.3% +$922 0.08% 118
2020
Q3
$392K Buy
1,544
+4
+0.3% +$991 0.1% 110
2020
Q2
$363K Sell
1,540
-463
-23% -$106K 0.1% 113
2020
Q1
$406K Buy
2,003
+8
+0.4% +$1.75K 0.13% 95
2019
Q4
$481K Buy
1,995
+6
+0.3% +$1.32K 0.12% 90
2019
Q3
$385K Buy
1,989
+8
+0.4% +$1.54K 0.11% 98
2019
Q2
$365K Buy
1,981
+91
+5% +$16.3K 0.1% 100
2019
Q1
$359K Hold
1,890
0.1% 108
2018
Q4
$368K Buy
1,890
+7
+0.4% +$1.37K 0.11% 107
2018
Q3
$390K Buy
1,883
+753
+67% +$148K 0.11% 101
2018
Q2
$209K Buy
1,130
+8
+0.7% +$1.42K 0.07% 121
2018
Q1
$191K Buy
1,122
+7
+0.6% +$1.28K 0.06% 130
2017
Q4
$194K Buy
1,115
+6
+0.5% +$1.06K 0.06% 124
2017
Q3
$207K Buy
1,109
+6
+0.5% +$1.06K 0.07% 112
2017
Q2
$190K Buy
1,103
+7
+0.6% +$1.14K 0.07% 116
2017
Q1
$180K Sell
1,096
-29
-3% -$4.82K 0.07% 118
2016
Q4
$164K Buy
1,125
+42
+4% +$6.32K 0.07% 117
2016
Q3
$181K Buy
1,083
+5
+0.5% +$846 0.08% 110
2016
Q2
$164K Buy
1,078
+6
+0.6% +$933 0.08% 113
2016
Q1
$161K Buy
1,072
+7
+0.7% +$1.04K 0.08% 108
2015
Q4
$173K Buy
1,065
+4
+0.4% +$629 0.09% 107
2015
Q3
$147K Buy
1,061
+5
+0.5% +$788 0.08% 113
2015
Q2
$162K Buy
1,056
+5
+0.5% +$801 0.08% 111
2015
Q1
$168K Buy
1,051
+4
+0.4% +$630 0.09% 107
2014
Q4
$167K Buy
1,047
+4
+0.4% +$623 0.09% 102
2014
Q3
$146K Buy
1,043
+4
+0.4% +$522 0.08% 113
2014
Q2
$123K Buy
1,039
+4
+0.4% +$463 0.07% 125
2014
Q1
$128K Buy
1,035
+5
+0.5% +$606 0.08% 122
2013
Q4
$118K Buy
+1,030
New +$117K 0.08% 104

Other funds holding AMGN

Capital Advisors Ltd's AMGN Position: Q2 2026 in Review

Capital Advisors Ltd reduced its Amgen (AMGN) stake by 0.6% in Q2 2026, selling an estimated $6.16K and leaving 2,998 shares worth $1.09M. The position accounts for 0.11% of the portfolio, ranked #124.

Capital Advisors Ltd first reported a position in AMGN in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.18M in Q4 2025. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Capital Advisors Ltd held 2,998 shares of Amgen worth $1.09M as of Q2 2026.
  • Capital Advisors Ltd sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
  • Amgen made up 0.11% of Capital Advisors Ltd's portfolio in Q2 2026, its #124 holding.
  • Capital Advisors Ltd first reported a position in Amgen in Q4 2013 and has held it in 51 quarters since.
  • Capital Advisors Ltd's Amgen position peaked at $1.18M in Q4 2025.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.